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ABSTRACT: Chiral cyclic ureas (2-imidazolinones) were prepared by the reaction of nitrones and isocyanoacetate esters using a 
multicatalytic system that combines a bifunctional Brønsted base-squaramide organocatalyst and Ag+ as Lewis acid. The reaction 
could be achieved with a range of nitrones derived from aryl- and cycloalkylaldehydes with moderate diastereo- and good enanti-
oselectivity. A plausible mechanism involving an initial formal [3+3] cycloaddition of the nitrone and isocyanoacetate ester, fol-
lowed by rearrangement to an aminoisocyanate and cyclization to the imidazolinone is proposed. 
Cyclic ureas, in particular 2-imidazolinones, are structural 
units often found in natural products,1  and biologically and 
pharmacologically interesting molecules, including HIV pro-
tease inhibitors,2  5-HT3 receptor and PX27 receptor antago-
nists,3  NK1 antagonists,4  and ACE inhibitor hypertensive 
drugs.5  Chiral imidazolidin-2-ones have also been widely 
utilized as chiral auxiliaries,6  chiral ligands,7  and intermedi-
ates in organic synthesis.8  For these reasons, many methodol-
ogies have been developed to generate these molecules. Ex-
amples include the carboxylation of 1,2-diamines,9  intramo-
lecular amidation reactions,10  intermolecular diamidation 
reactions,11  or reactions involving isocyanates.12  However, 
only few procedures allow the enantioselective formation of 
the 2-imidazolinone ring and a C-C bond simultaneously.13   
In recent years, isocyanoacetate esters have emerged as 
formal 1,3-dipoles that can react with different electrophilic 
unsaturated functional groups to give five-membered, nitro-
gen-containing heterocycles.14  Thus, chiral imidazolines have 
been prepared by several authors from isocyano acetates and 
imines under different conditions.15  Within this area, our 
group has contributed with the development of a highly enan-
tioselective synthesis of 2-oxazolines from ketones and isocy-
anoacetate esters using a multicatalytic system that combines a 
bifunctional squaramide-Brønsted base and silver as Lewis 
acid.16  Wishing to extend the structural diversity of com-
pounds that can be prepared enantioselectively with this chem-
istry we became interested in studying other nitrogen-
containing electrophiles. Herein we report the reaction of 
isocyanoacetates with nitrones, which are typical 1,3-dipoles 
used in cycloaddition reactions. The reaction provided chiral 
2-imidazolinones instead of the expected [3+3] cycloaddition 
products.17  
Scheme 1. Synthesis of imidazolines and imidazolinones from 
imine derivatives 
 
The reaction of nitrone 1a and tert-butyl isocyanoacetate 
(2a) was chosen to optimize the reaction conditions (Table 1). 
Following our methodology previously developed for the 
reaction with ketones, we tested different chiral squaramide 
organocatalysts in the presence of silver oxide in tert-butyl 
methyl ether as the solvent (Table 1). SQ3 and SQ4, which are 
derivatives of dihydro 9-deoxy-9-epi-9-aminoquinine and 2,6-
disubstituted anilines, provided the highest enantioselectivity 
for the major trans diastereomer (Table 1, entries 3 and 4).  
 
Table 1. Screening of organocatalysts.a 
 
entry SQ t (d) yield (%)b trans:cisc eetrans (%)d 
1 SQ1 1 83 46:54 70 
2 SQ2 1 73 48:52 70 
3 SQ3 1 75 71:29 84 
4 SQ4 2 89 61:39 84 
5 SQ5 2 70 55:45 58 
6 SQ6 7 43 52:48 83 
a Conditions: 1a (0.13 mmol), 2a (0,17 mmol), SQ (0.013 
mmol), Ag2O (0.0063 mmol), TBME (1 mL), room temperature. b 
Isolated yield after column chromatography. c Determined by 1H 
NMR. d Determined by HPLC over chiral stationary phases. 
Table 2. Effect of solvents and concentration.a 
entry SQ solvent [1a]b  t (d) yield (%)c trans:cisd eetrans( %)e 
1 SQ3 MTBE 0.13 1 75 71:29 84/-6 
2 SQ4 MTBE 0.13 1 83 61:39 84/-13 
3 SQ3 dioxane 0.13 2 70 71:29 90/30 
4 SQ3 toluene 0.13 2 71 70:30 87/3 
5 SQ3 Et2O 0.13 2 70 69:31 79/6 
6 SQ3 EtOAc 0.13 2 60 65:35 79/6 
7 SQ3 DCM 0.13 2 39 41:59 59:12 
8 SQ3 dioxane 0.063 2 46 73:27 99/3 
9 SQ4 dioxane 0.063 3 60 50:50 78/21 
10 SQ4 MTBE 0.063 2 84 68:32 88/-9 
11f SQ4 MTBE 0.063 4 78 67:37 88/-3 
12g SQ4 MTBE 0.063 1 60 66:33 88/-2 
13 SQ4 MTBE 0.042 4 78 71:29 90/-3 
a Conditions: 1a (0.13 mmol), 2a (0.17 mmol), SQ (0.013 
mmol), Ag2O (0.0063 mmol), solvent, room temperature. b Molar 
concentration of 1a. c Isolated yield after column chromatography. 
d Determined by 1H NMR. e Determined by HPLC over chiral 
stationary phases. f Reaction carried out at 0 C. g Reaction car-
ried out at 35 C 
 Further optimization was carried out first with organocata-
lyst SQ3 (Table 2). From the different solvents tested (Table 
2, entries 3-7), dioxane allowed to obtain the best diastereo- 
(trans:cis 71:29) and enantioselectivity (90%). By performing 
the reaction under more dilute conditions, the ee could be 
raised up to 99%, however with a huge detriment of yield 
(Table 2, entry 8). Other attempts to increase the yield and/or 
stereoselectivity with SQ3 in dioxane were unsuccessful (see 
SI). Therefore, we turned our attention back to squaramide 
SQ4. This organocatalyst was tested in dioxane as the solvent 
under identical conditions as those previously used for SQ3 
providing compound 3aa as a 1:1 mixture of diastereomers in 
78% ee (Table 2, entry 9). Since dioxane seemed not to be a 
good solvent for this catalyst, the reaction was repeated in 
MTBE under dilute conditions yielding the expected urea 3aa 
with fair diastereoselectivity (dr = 68:32) and high enantiose-
lectivity (88% ee), without detriment in the yield (Table 1, 
entry 10). Attempts to improve the stereoselectivity by chang-
ing the reaction temperature were unsuccessful (Table 1, en-
tries 11 and 12). Finally, a small increase of diastereo- and 
enantioselectivity could be obtained by further dilution of the 
reaction mixture (Table 1, entry 13). 
 Given the similar results obtained either with SQ3 in diox-
ane (Table 2, entry 3) or with SQ4 in MTBE (Table 2, entry 
13), both reaction condition manifolds were tested with two 
nitrones 3b and 3c derived from p-substituted aldehydes 
(Scheme 2). The SQ3/dioxane system provided the expected 
ureas 3ba and 3ca with similar or lower stereoselectivities to 
those obtained with SQ4/MTBE, and in significant lower 
yields. Accordingly, the study of the reaction scope was con-
tinued under the optimized conditions for SQ4 in MTBE. In 
general, the reaction conditions could be applied to the addi-
tion of tert-butyl isocyanoacetate (2a) with a large range of N-
phenylnitrones derived from substituted benzaldehydes bear-
ing substituents of different electronic nature in different posi-
tions of the aromatic ring. The chiral 2-imidazolinones 3aa-
3ka were obtained with fair to good diastereoselectivity (62:38 
to 78:22) and high enantiomeric excesses (67-94%). The pres-
ence of electron-donating groups (Me, MeO) (3ba, 3ea, 3fa, 
3ia), favored higher enantioselectivities than electron-
withdrawing groups (Br, NO2) (3ca, 3da, 3ga, 3ha, 3ja, 3ka) 
regardless of the position of these groups on the aromatic ring. 
The reaction also worked with the N-phenyl nitrone derived of 
the bulky 2-naphthylcarbaldehyde delivering urea 3la with 
good yield, good dr and excellent ee. 2-Pyridine-derived 
nitrone 1m reacted with tert-butyl isocyanoacetate to give 
compound 3ma in quantitative yield, with good diastereose-
lectivity (dr = 88:12) and excellent enantioselectivity (95% 
ee). This result contrasts with those obtained with nitrones 
derived from nitrobenzaldehydes and it is quite surprising 
since both the pyridine and the nitrophenyl are electron-poor 
rings. Furthermore, the enantiomer of 3ma could be also ob-
tained with very good result by using squaramide SQ7, de-
rived from dihydroquinidine, in place of SQ4. Cycloalkyl-
carbaldehyde-derived nitrones were also suitable substrates for 
the reaction. Compounds 3na and 3oa, bearing a cyclohexyl o 
cyclopropyl substituent, respectively, were obtained with very 
high enantiomeric excesses. The effect of the substituent on 
the N atom of the nitrone was also tested. N-(4-chlorophenyl) 
imine reacted with tert-butyl isocyanoacetate to give com-
pound 3pa with good yield but moderate diastereo- and enan-
tioselectivity. On the other hand, the N-(4-methoxyphenyl) 
nitrone provided compound 3qa with good enantioselectivity 
(91% ee) but in very low yield (24%), unfortunately. Finally, 
we tested the reaction with benzyl (2b) and methyl (2c) isocy-
anoacetates, none of them performing better than tert-butyl 
isocyanoacetate. The reaction could be carried out at 1 mmol 
 
scale without noticeable effect on the results (Scheme 2, foot-
note c). 
Scheme 2. Scope of the reaction of nitrones 1 and isocyano-
acetates 2.a 
 
a Reaction conditions: 1 (0.25 mmol), 2 (0.33 mmol), SQ4 (0.025 
mmol), Ag2O (0.013 mmol), MTBE (6 mL), rt. b Reaction condi-
tions: 1 (0.13 mmol), 2 (0.17 mmol), SQ3 (0.013 mmol), Ag2O 
(0.0063 mmol), dioxane (1 mL), rt. c Reaction carried out with 1 
mmol of 1a. d Reaction carried out with squaramide SQ7. Yields 
after column chromatography, dr determined by 1H NMR, ee 
determined by HPLC. 
 Scheme 3 outlines some synthetic modifications of com-
pounds 3. Deprotection of the tert-butyl ester can be achieved 
with trifluoroacetic acid to give acid 4 which can be converted 
into alcohol 5 after reduction with borane. On the other hand, 
the absolute stereochemistry of compounds 3 was determined 
by chemical correlation with a compound of known stereo-
chemistry (Scheme 3). Thus, the N atom in compound 3qa 
was deprotected with CAN to give compound 6, which after 
hydrolysis of the tert-butyl ester with trifluoroacetic acid 
yielded acid 7. Finally, Fisher esterification gave the ester 8, 
which showed identical spectroscopic features and optical 
rotation sign as those described in the literature for (4R,5S)-
8,19  allowing to assign the stereochemistry of compound 3qa. 
The absolute stereochemistry of the remaining compounds 3 
was assigned upon the assumption of a uniform mechanistic 
pathway. 
Scheme 3. Synthetic modifications and determination of the 
absolute stereochemistry of compounds 3.a  
 
a Reaction conditions: a) CF3CO2H/CH2Cl2, rt, 5h, 89%. b) 
BH3·SMe2, THF, rt, 24 h, 76%. c) CAN (3.0 equiv), MeCN/H2O, 
0 C to rt, 1 h, 75%. d) CF3CO2H/CH2Cl2, rt, 7 h, 87%. e) H2SO4 
(cat), MeOH, reflux, 6 h, 89% 
Scheme 4. Proposed catalytic cycle for the synthesis of 2-
imidazolinones 
  
Scheme 4 shows a plausible mechanism for the formation of 
cyclic ureas 3. Thus, deprotonation of the isocyanoacetate 2 by 
 
the basic bifunctional squaramide assisted by silver would 
give the corresponding enolate I that would undergo nucleo-
philic addition to the C-N double bond of nitrone 1 to give 
intermediate II, followed by intramolecular alkoxide addition 
to the isocyanide giving the formal [3+3] cycloaddition prod-
uct III. This would rearrange to the amino isocyanate IV, 
which after amide addition would give the deprotonated imid-
azolinone V. Finally, protonation by the catalyst conjugate 
acid provides product 3 and releases the catalyst. 
 In summary, we have developed an unprecedented catalyt-
ic, connective, diastereo- and enantioselective synthesis of 
cyclic ureas (2-imidazolinones) by reaction of isocyanoacetate 
esters and nitrones. The reaction is catalyzed by a bifunctional 
Brønsted base-squaramide organocatalyst and Ag+ as Lewis 
acid and provides the chiral trans-2-imidazolinones with good 
diastereoselectivity and high enantioselectivity in most of the 
examples tested, applicable to nitrones derived from aromatic 
and heteroaromatic aldehydes as well as nitrones derived from 
cycloalkylcarbaldehydes. The reaction most probably involves 
the initial formal [3+3] cycloaddition of the nitrone and isocy-
anoacetate ester, followed by rearrangement to an amino iso-
cyanate and cyclization to the imidazolinone. 
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